Rodrigues, M., Winkler, K., Svirydenka, H., Nilica, B., Uprimny, C., & Virgolini, I. (2021). Long-Term Survival and Value of (18)F-FDG PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with Second Peptide Receptor Radionuclide Therapy Course with (177)Lu-DOTATATE. Life (Basel).
استشهاد بنمط شيكاغوRodrigues, Margarida, Kevin-Klaus Winkler, Hanna Svirydenka, Bernhard Nilica, Christian Uprimny, و Irene Virgolini. "Long-Term Survival and Value of (18)F-FDG PET/CT in Patients With Gastroenteropancreatic Neuroendocrine Tumors Treated With Second Peptide Receptor Radionuclide Therapy Course With (177)Lu-DOTATATE." Life (Basel) 2021.
MLA استشهادRodrigues, Margarida, et al. "Long-Term Survival and Value of (18)F-FDG PET/CT in Patients With Gastroenteropancreatic Neuroendocrine Tumors Treated With Second Peptide Receptor Radionuclide Therapy Course With (177)Lu-DOTATATE." Life (Basel) 2021.